Recurrent venous thromboembolism: Diagnosis and management

Current Opinion in Pulmonary Medicine

Volumn 6, Issue 4, 2000, Pages 330-334

  Huisman, Menno V ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; D DIMER;

ANTICOAGULANT THERAPY; BLEEDING; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; HUMAN; IMPEDANCE PLETHYSMOGRAPHY; PHLEBOGRAPHY; RECURRENT DISEASE; REVIEW; THROMBOEMBOLISM; TREATMENT PLANNING; VEIN THROMBOSIS;

EID: 0033927153     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: 10.1097/00063198-200007000-00014     Document Type: Review

References (27)

1. 1 Hull RD, Carter C, Jay R: The diagnosis of acute recurrent DVT: a diagnostic challenge. Circulation 1983, 67:901-906.
2. 2 Huisman MV, Büller HR, ten Cate JW: Utility of impedance plethysmography in the diagnosis of recurrent deep-vein thrombosis. Arch Intern Med 1988, 148:681-683.
3. 3 Kearon C, Gent M, Hirsh J, et al.: A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thrombembolism. N Engl J Med 1999, 340:901-907.
4. 4 Prandoni P, Lensing A, Cogo A, et al.: The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 1996, 125:1-7.
5. 5 Leclerc J, Jay R, Hull RD: Recurrent leg symptoms following DVT: a diagnostic challenge. Arch Intern Med 1985, 145:1867-1869.
6. 6 Heijboer H, Jongbloets LM, Büller HR, et al.: Clinical utility of real time compression ultrasonography for diagnostic management of patients with recurrent venous thrombosis. Acta Radiol 1992, 33:297-300.
7. 7 Prandoni P, Cogo A, Bernardi E, et al.: A simple ultrasound approach for detection of recurrent proximal-vein thrombosis. Circulation 1993, 88:1730-1735.
8. 8 Murphy TP, Cronan JJ: Evolution of deep venous thrombosis: a prospective evaluation with ultrasound. Radiology 1990, 177:543-548.
9. 9 The diagnostic approach to acute venous thromboembolism. Clinical Practice Guideline. Am J Respir Crit Care Med 1999, 160:1043-1066. Comprehensive report of clinical practice guidelines for the diagnosis of venous thromboembolism.
10. 10 Spritzer CE, Norconk JJ, Sostman HD, et al.: Detection of deep venous thrombosis by MRI. Chest 1993, 104:54-60.
11. 11 Erdman WA, Jayson HT, Redman HT, et al.: Deep venous thrombosis of extremities: role of MRI in the diagnosis. Radiol 1990, 174:425-431.
12. 12 Bounameaux H, Cirafici P, DeMoerloose P, et al.: Measurement of D-dimer in plasma as a diagnostic aid in suspected pulmonary embolism. Lancet 1996, 337:196-200.
13. 13 Kraaijenhagen RA, Lensing A, Lijmer JG, et al.: Diagnostic strategies for the management of patients with clinically suspected deep vein thrombosis. Curr Opin Pulm Med 1997, 3:268-274.
14. 14 Carson JL, Kelley MA, Duff A, et al.: The clinical course of pulmonary embolism. N Engl J Med 1992, 326:1240-1245.
15. 15 van Seek EJR, Kuijer PMM, Büller HR, et al.: The clinical course of patients with pulmonary embolism. Arch Intern Med 1997, 157:2593-2598.
16. 16 National Heart, Lung, and Blood Institute: Urokinase Pulmonary Embolism Trial-Phase I results. JAMA 1970, 214:2163-2172.
17. 17 Schulman S, Granqvist S, Holmström M, et al.: The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. N Engl J Med 1997, 336:393-398.
18. 18 Shulman S: Oral anticoagulation in venous thromboembolism: decisions based on more than mere feelings. J Intern Med 1999, 245:399-403.
19. 19 Lane DA, Mannucci PM, Bauer KA, et al.: Inherited thrombophilia: Part 2. Thromb Haemostasis 1996, 76:824-834.
20. 20 Lindmarker P, Schulman S, Sten-Linder M, et al.: The risk of recurrent venous thromboembotism in carriers and non-carriers of the G1691A allelle in the coagulation factor V gene and the G20210A allele in the prothrombin gene. Thromb Haemostasis 1999, 81:684-689. Prospective study with a large inception cohort establishing the risk for recurrent VTE in patients with a first venous thrombosis or pulmonary embolism and either factor V Leiden mutation or G20210A prothrombin gene.
21. 21 Rintelen C, Pabinger I, Knöbl P, et al.: Probability of recurrence of thrombosis in patients with and without factor V Leiden. Thromb Haemostasis 1996, 75:229-232.
22. 22 Eichinger S, Pabinger I, Stüpflen A, et al.: The risk of recurrent venous thromboembolism in patients with and without factor V Leiden. Thromb Haemostasis 1997, 77:624-628.
23. 23 Eichinger S, Minar E, Hirschl M, et al.: The risk of early recurrent venous thromboembolism after oral anticoagulan therapy in patients with the G20210A transition in the prothrombin gene. Thromb Haemostasis 1999, 81:14-17.
24. 24 De Stefano V, Martinelli I, Mannucci PM, et al.: The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation. New Engl J Med 1999, 341:801-806.
25. 25 Lensing A, Prins M: Recurrent deep vein thrombosis and two coagulation factor gene mutations: Quo vadis? Thromb Haemostasis 1999, 82:1564-1566.
26. 26 Simioni P, Prandoni P, Lensing A, et al.: The risk of recurrent venous thromboembolism in patients with an Arg506Gln mutation in the gene for factor V. New Engl J Med 1997, 336:399-403.
27. 27 Ridker PM: Longterm, low-dose warfarin among venous thrombosis patients with and without factor V Leiden mutation: rationale and design for the Prevention of Recurrent Venous Thromboembolism (PREVENT) trial. Vascular Med 1998, 3:67-73.